06 / Funding
Published reporting, research and funding records filed under Funding.
Standing description
Cell-Ag has published 8 records under Funding, covering reporting, research digests and funding calls. The most recent entry is dated 24 September 2026. The organisations named most often in this coverage are Upside Foods, Believer Meats, Tufts University.
24 September 2026 · Cultivated meat · Manufacturing · Funding · Bioprocess
A patent roundup highlights how Hanwha Solutions, Tufts University and IamFluidics are addressing culture-medium expense and cell-recovery losses, while leaving commercial-scale performance and patent outcomes unsettled.
24 September 2026 · Cultivated meat · Regulation · Manufacturing · Funding · Bioprocess
BeneMeat brought Czech meat-sector representatives inside its pilot facility to discuss cultivated-cell production, labeling and adoption, presenting incumbent processors as prospective customers rather than competitors.
24 September 2026 · Manufacturing · Funding · Bioprocess
Believer Meats’ Israeli trustee has lengthened the bidding period for the insolvent cultivated-meat company’s patents and production know-how as a separate sale advances for its North Carolina factory.
24 September 2026 · Fermentation · Manufacturing · Funding
C16 Biosciences has expanded its Palmless fermentation platform into food with a cocoa butter equivalent, as Saku Biosciences separately tackles strain-selection problems that can undermine commercial biomanufacturing.
24 September 2026 · Fermentation · Regulation · Manufacturing · Funding
Michroma and We Are Palta described how disciplined messaging, design and investor materials shaped a precision-fermentation fundraising campaign, while highlighting the cost of communicating complex food biotechnology.
24 September 2026 · Fermentation · Regulation · Manufacturing · Funding
A GFI APAC study examines why Chinese fermentation manufacturers are applying pharmaceutical and vitamin infrastructure to mycoprotein and precision fermentation, as policy backing meets oversupply and geopolitical risk.
24 September 2026 · Fermentation · Regulation · Manufacturing · Funding · Bioprocess
Australian precision-fermentation company All G has entered the US lactoferrin market with an iron-depleted bovine-equivalent protein, pairing commercial production claims with a strategy aimed at nutrition and supplement formulators.
24 September 2026 · Fermentation · Funding
A podcast profile examines how B-COS used Ghent University’s new spin-out terms to commercialize precision-fermented crop bioactives while navigating investor concerns and grant constraints in Belgium.